Vecuronium neuromuscular block in a patient with Charcot-Marie-tooth syndrome

Anesthesia and Analgesia

Volumn 84, Issue 4, 1997, Pages 927-928

  Baraka, Anis S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; NEOSTIGMINE; NITROUS OXIDE; OXYGEN; PETHIDINE; PROMETHAZINE; THIOPENTAL; VECURONIUM;

ADOLESCENT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; DOSE RESPONSE; FEMALE; FOOT MALFORMATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MUSCLE RELAXATION; NERVE DEGENERATION; NEUROMUSCULAR BLOCKING; PERIPHERAL NERVE; PRIORITY JOURNAL; TENDON TRANSFER;

ADOLESCENT; CHARCOT-MARIE-TOOTH DISEASE; FEMALE; HUMANS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0030960948     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199704000-00043     Document Type: Article

References (16)

1. Kyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. Arch Neurol 1968;18:603-25.
2. Kotani N, Hirota K, Anzawa N, et al. Motor and sensory disability has a strong relationship to induction dose of thiopental in patients with the hypertrophic variety of Charcot-Marie-Tooth syndrome. Anesth Analg 1996;82:182-6.
3. Antogini JF. Anaesthesia for Charcot-Marie-Tooth disease: a review of 86 cases. Can J Anaesth 1992;39:398-400.
4. Greenberg RS, Parker SD. Anesthetic management for the child with Charcot-Marie-Tooth disease. Anesth Analg 1992;74:305-7.
5. 2 anesthesia. Anesth Analg 1989;68:20-4.
6. Meretoja OA, Wirtavuori K, Neuvonen PJ. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 1988;67:21-6.
7. Rovrik K, Husby P, Gramstad L, et al. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular block. Br J Anaesth 1988;61:180-5.
8. Mirakhur RK, Ferres CJ. Muscle relaxation with an infusion of vecuronium. Eur J Anaesth 1984;1:353-9.
9. Elliot JM, Bion JF. The use of neuromuscular blocking drugs in intensive care practice. Acta Anaesthesiol Scand Suppl 1995;109(39):70-82.
10. Martyn JAJ, White DA, Gronert GA, et al. Up- and down-regulation of skeletal muscle acetylcholine receptors. Anesthesiology 1992;76:822-3.
11. Yanez P, Martyn JAJ. Prolonged d-tubocurarine infusion and/or immobilization causes upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats. Anesthesiology 1996;84:384-91.
12. Fambrough DM. Control of acetylcholine receptors in skeletal muscle. Physiol Rev 1979;59:165-227.
13. Hogue CW Jr, Itani MS, Martyn JAJ. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction. Anesthesiology 1990;73:703-9.
14. Fergusson RJ, Wright DJ, Willey RF, et al. Suxamethonium is dangerous in polyneuropathy. BMJ 1981;282:298-9.
15. Feldman JM. Cardiac arrest after succinylcholine administration in a pregnant patient recovered from Guillan-Barré syndrome. Anesthesiology 1990;72:942-4.
16. Walton JD, Farman JV. Suxamethonium hyperkalaemia in uraemic neuropathy. Anaesthesia 1973;28:666-8.